Anti-aquaporin-4 IgG in patients presenting with unilateral optic neuritis: A cohort study

International Journal of Preventive Medicine

Volumn 3, Issue 9, 2012, Pages 612-615

  Etemadifar, Masoud ^a,b,c   Abtahi, Mohammad Ali ^c,d   Razmjoo, Hassan ^c,d   Abtahi, Seyed Hossein ^a,c   Dehghani, Ali Reza ^c,d   Abtahi, Zahra Alsadat ^c,d   Akbari, Mojtaba ^c   Mazaheri, Shahir ^e   Maghzi, Amir Hadi ^a,c,f  

^a Isfahan Research Committee of Multiple Sclerosis (IRCOMS)   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Anti aquaporin 4 IgG; Iran; Isfahan; Multiple sclerosis; Neuromyelitis optica; Optic neuritis

Indexed keywords

AQUAPORIN 4 ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; IMMUNE STATUS; IMMUNOFLUORESCENCE TEST; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; OPTIC NEURITIS; OUTCOME ASSESSMENT; PROGNOSIS; QUALITATIVE ANALYSIS; RELAPSE; SEROPREVALENCE;

EID: 84867059984     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hickman SJ, Dalton CM, Miller DH, Plant GT. Management of acute optic neuritis. Lancet 2002;360:1953-62.
2. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet 2004;364:2106-12.
3. Hinson SR, Pittock SJ, Lucchinetti CF, Roemer SF, Fryer JP, Kryzer TJ. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 2007;69:2221-31.
4. Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 2007;130:1235-43.
5. ShimizuJ, Hatanaka Y, Hasegawa M, Iwata A, Sugimoto I, Date H, et al. IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology 2010;75:1423-7.
6. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999;53:1107-14.
7. Jarius S, Frederikson J, WatersP, PaulF, Akman-DemirG, Marignier R, et al. Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis. J Neurol Sci2010;298:158-62.
8. Petzold A, Pittock SJ, Lennon VA, Maggiore C, Weinshenker BG, Plant GT. Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis. J Neurol Neurosurg Psychiatry 2010;81:109-11.
9. Matiello M, Lennon VA, Jacob A, Pittock SJ, Lucchinetti CF, Wingerchuk DM, et al. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 2008;70:2197-200.
10. Polman CH, Reingold SC, Edan G, Filippi M, HartungHP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005;58:840-6.
11. Wingerchuk DM, Lennon VA, Pittock SJ, LucchinettiCF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-9.
12. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol 2007;6:805-15.
13. Pirko I, Blauwet Lk, Lesnick TG, Weinshenker BG. The Natural History of Recurrent Optic Neuritis. Arch Neurol 2004;61:1401-5.
14. Etemadifar M, Abtahi SH, Dehghani A, Abtahi MA, Akbari M, Tabrizi N, et al. Myasthenia Gravis during the Course of Neuromyelitis Optica. Case Rep Neurol 2011;3:268-73.